Fine-resolution mapping of micro vasculature after placental transport of acoustic nanodrops

Information

  • Research Project
  • 9983114
  • ApplicationId
    9983114
  • Core Project Number
    R21HD097485
  • Full Project Number
    5R21HD097485-02
  • Serial Number
    097485
  • FOA Number
    PA-18-482
  • Sub Project Id
  • Project Start Date
    8/1/2019 - 6 years ago
  • Project End Date
    7/31/2021 - 4 years ago
  • Program Officer Name
    TOYAMA, REIKO
  • Budget Start Date
    8/1/2020 - 5 years ago
  • Budget End Date
    7/31/2021 - 4 years ago
  • Fiscal Year
    2020
  • Support Year
    02
  • Suffix
  • Award Notice Date
    7/4/2020 - 5 years ago

Fine-resolution mapping of micro vasculature after placental transport of acoustic nanodrops

Project Summary/Abstract A fundamental question in developmental biology is how speci?c molecules and genetic pathways control mor- phogenesis during embryonic development. Recent studies have shown that many of the same molecules and genetic pathways affecting organogenesis are also involved in vascular development and patterning during an- giogenesis. A major challenge is to develop rapid, in vivo mouse-embryo imaging methods that provide the ability to analyze organ and vascular patterning with ?ne resolution. The goal of this proposal is to establish the feasibility of transporting acoustic nanodrops (NDs) through the pla- centa in order to map vasculature of the embryonic mouse, in utero, with super-resolution, plane-wave ultrasonic imaging. Per?uorocarbon NDs can be vaporized by an acoustic excitation and converted to gas ?lled acoustic contrast agents. After vaporization, the NDs reach a size on the order of 1 m and appear as bright points in an ultrasound image. We will formulate ND compositions of different size, charge and per?uorocarbon core. We will evaluate ?uorescent ND compositions to determine which NDs, after injection into the maternal mouse tail vein, pass through the placenta into the embryonic circulation and select the most promising composition in terms of size and transport ef?ciency. We will quantify the acoustic pressures at which the selected NDs vaporize. The most promising ND in terms of vaporization threshold will be injected into the maternal tail vein of a mouse and, after entering the embryonic circulation, the NDs will be activated with an acoustic pulse. Plane-wave ul- trasound and super-resolution methods will then be utilized to detect and localize activated NDs at ?ne-spatial and -temporal resolution as they move through the embryonic circulation. Feasibility of vascular mapping in a single plane will be evaluated. Because this approach relies on tracking point targets, the length scale that can be resolved, on the order of 20 m, is much less than the lateral beamwidth of the 18-MHz linear-array acous- tic ?eld. The ability to activate NDs that have passed through the placenta and to perform noninvasive, in utero contrast-enhanced imaging has high potential to revolutionize the way we study organogenesis and angiogenesis in widely utilized models of normal and abnormal embryonic development.

IC Name
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT
  • Activity
    R21
  • Administering IC
    HD
  • Application Type
    5
  • Direct Cost Amount
    161135
  • Indirect Cost Amount
    44221
  • Total Cost
    205356
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    865
  • Ed Inst. Type
  • Funding ICs
    NICHD:205356\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ITD
  • Study Section Name
    Imaging Technology Development Study Section
  • Organization Name
    RIVERSIDE RESEARCH INSTITUTE
  • Organization Department
  • Organization DUNS
    046822615
  • Organization City
    NEW YORK
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    100382609
  • Organization District
    UNITED STATES